SAN FRANCISCO--(BUSINESS WIRE)--Clarify Health, the leading cloud analytics company delivering real-world insights to healthcare and life sciences organizations, launched new applications of its anonymized patient-level social determinants of health (SDoH) insights to help life sciences companies on their patient-first missions. With real world evidence (RWE) software products, Clarify Growth and Clarify Portfolio, pharmaceutical and biotechnology companies gain the unprecedented ability to explore and understand how patients’ journeys, treatment decisions, and outcomes are impacted by non-medical factors such as race, income, transportation access, housing stability, education level, health literacy, and propensity to exercise.
“The pharmaceutical industry has a critical role to play in advancing health equity,” said Jean Drouin, MD, CEO, Clarify Health. “Clarify’s real-world insights provide a window into how medical care and social and behavioral determinants of health interconnect to influence each patient’s journey. Our RWE products help evaluate health disparities, such as discrepancies between patients who are diagnosed and those who are treated based on race and socioeconomic status, to ensure eligible patients have equal access to treatment.”
Clarify has access to vast sources of clinically relevant consumer data for all Americans. With this launch, its life sciences products draw upon an expanded and extensive set of individual-level, de-identified SDoH factors, which are linked together with government and commercial claims, clinical, and prescription and dispensing data. Its cloud software uses machine learning to interrogate these longitudinal patient journeys and identify real-world health disparities within patient cohorts. Clarify’s on-demand insights help its customers ensure that their healthcare provider outreach programs and patient assistance programs are the best fit to get the right treatment to the right patient at the right time.
“Our pharma and biotech customers are increasingly asking for socio-behavioral insights to ensure patients with heath disparities get accurately diagnosed and get on the right therapy,” says Todd Gottula, President, Clarify Health. “Our patented AI insights platform delivers the nation’s largest collection of de-identified patient journeys, enhanced with the greatest breadth of individual-level SDoH factors. Drawing upon these journeys, our software precisely pinpoints the needs of any patient cohort and surfaces the most impactful real-world opportunities to improve outcomes.”
About Clarify Health
Clarify Health is a technology company whose patented AI insights platform transforms healthcare data into actionable insights for providers, health plans, and life sciences companies. Its platform powers highly automated business applications that enable customers to drive growth, optimize networks, improve care delivery, manage population health, maximize value-based care performance, and commercialize pharmaceutical and biotechnology products – all of which depend on a superior understanding and trending of individual patient journeys and cohorts. Its intuitive cloud software enables on-demand interrogation of over 300 million longitudinal patient journeys, allowing healthcare organizations to leapfrog from traditionally cumbersome and manual analytics to self-service insights that result in better health and outcomes. Learn more at clarifyhealth.com.
About Clarify Growth
Clarify Growth is a cloud-based real-world evidence software used by pharmaceutical and biotechnology commercial teams to boost brand performance at launch and beyond. It offers instant access to precision insights on patient cohorts, health care providers, and market intelligence, including essential functionalities like SDoH-decorated patient journeys, configurable HCP scores, and CRM integration.
About Clarify Portfolio
Clarify Portfolio is a cloud-based real-world evidence software used by pharmaceutical and biotechnology business development teams to quickly and precisely value potential partnership deals and explore new market opportunities. It is a self-service, on-demand product that delivers insights into any market, therapeutic area, indication, and patient cohort in seconds.
